Pharmaceutical injectables are minimally invasive aesthetic facial treatments to address wrinkles and sagging of the face. There are currently three formulations of botulinum toxin type A (BTX-A) approved by the FDA in association with cosmetic use. This includes Botox, Dysport and Xenamin.
The first BTX-A was approved in 2002 with Botox (onabotulinumtoxinA) regarding cosmetic use. Dysport (abobotulinumtoxinA) was approved for the same purpose in 2009. Xeomin (incobotulinumtoxinA) was later approved in 2011.
Injections smooth glabellar frown lines between the eyebrows and have the potential to temporarily alter aspects of the face slightly. They may also be used in combination with other minimally invasive agents and procedures.
Los-Angeles-Dysport-before-after-5*
THE APPEAL OF DYSPORT
Botox was first approved for the therapeutic treatment of eye muscles spasm in 1989. The FDA approved Botox for cosmetic use in 2002, Dysport in 2009 and Xeomin in 2011. Dysport has been gaining traction ever since, with it now offered as a Botox alternative. In some clinical trials, Dysport worked better than Botox. Though both are similar, botulinum toxins are not identical or interchangeable. Different properties of each require independent dosage.
However, all botulinum toxins inhibit the release of acetylcholine, a neurotransmitter. The toxins are also produced by various strains of the bacteria clostridium botulinum.
DYSPORT WRINKLE TREATMENT BASICS
Dysport is purified to a nontoxin protein. It blocks the neurotransmission of muscle contraction due to the inhibition of acetylcholine. Wrinkles thus diminish in areas where muscles are weakened or paralyzed. It is also often incorporated into an anti-aging wrinkle treatment.
It treats cosmetic, therapeutic and medical issues, including:
- Temporary removal of wrinkles
- Severe underarm sweating
- Cervical dystonia
- Blepharospasm
- Strabismus
Before and After: This Los Angeles patient opted for Dysport to address his horizontal forehead lines.*
DYSPORT VERSUS BOTOX
While the core molecule of Botox and Dysport is similar, Dysport has fewer surrounding proteins. This may allow for greater acceptance by the body. Additionally, it may also break down slower than Botox in some clinical trials.
A practical approach to injectables is that if Botox under delivers, Dysport should be considered and vice versa. When we suspect the body has built a tolerance to Botox we use Dysport.
LOS ANGELES DYSPORT TREATMENT
Dysport is available at many clinics and practices throughout Los Angeles, including Fine Touch Dermatology. Some doctors and medical professionals prefer one formulation to another. However, individual results differ due to patient physiology. Aesthetic results also vary based on the artistry, expertise and expertise of the medical professional. A board certified specialist should always be consulted for any cosmetic procedure.
Dysport may be a more suitable alternative to Botox for some patients.*